Chemical activators of Trav7d-3 include a variety of compounds that initiate a cascade of intracellular events leading to the activation of this protein. Forskolin is known to directly activate adenylyl cyclase, which increases intracellular cAMP levels. The elevated cAMP then activates protein kinase A (PKA), which has the capacity to phosphorylate Trav7d-3, leading to its activation. Another activator, Phorbol 12-myristate 13-acetate (PMA), functions by activating protein kinase C (PKC). Activated PKC can phosphorylate Trav7d-3, enabling its functional activation. Ionomycin, by increasing intracellular calcium levels, can activate calmodulin-dependent kinases (CaMK), which can then phosphorylate and activate Trav7d-3.
Similarly, Dibutyryl-cAMP, a cAMP analog, can activate PKA, which in turn can lead to the phosphorylation and activation of Trav7d-3. Okadaic Acid and Calyculin A are both inhibitors of protein phosphatases 1 and 2A, which maintain Trav7d-3 in a phosphorylated and active state by preventing its dephosphorylation. Anisomycin activates the MAPK/ERK pathway, leading to Trav7d-3 activation through phosphorylation by ERK. Another cAMP analog, 8-Bromo-cAMP, activates PKA, which can phosphorylate and activate Trav7d-3. Chelerythrine, although a PKC inhibitor, under specific conditions can activate certain PKC isoforms, leading to the activation of Trav7d-3. Bisindolylmaleimide I, while selectively inhibiting PKC, can lead to the compensatory activation of alternative pathways that result in the activation of Trav7d-3. Staurosporine, despite being a broad-spectrum kinase inhibitor, can activate certain kinases through feedback loops, which can lead to Trav7d-3 activation. Lastly, (-)-Epigallocatechin Gallate (EGCG) inhibits specific phosphatases, which increases the phosphorylation and subsequent activation of proteins, potentially including Trav7d-3. Each of these chemicals, through their interaction with different cellular pathways and enzymes, ensures the phosphorylation and activation state of Trav7d-3 is achieved.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can then phosphorylate and activate Trav7d-3 as part of downstream signaling. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium levels, which can activate calmodulin-dependent kinase (CaMK), potentially leading to the phosphorylation and activation of Trav7d-3. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cAMP analog that activates PKA, and subsequently, PKA can phosphorylate and activate Trav7d-3. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid inhibits protein phosphatases 1 and 2A, preventing dephosphorylation and maintaining Trav7d-3 in an activated phosphorylated state. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A, similar to Okadaic Acid, inhibits protein phosphatases, leading to sustained phosphorylation and activation of Trav7d-3. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates the MAPK/ERK pathway, which could lead to the activation of Trav7d-3 through phosphorylation by ERK. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP is a cell-permeable cAMP analog that specifically activates PKA, which could then phosphorylate and activate Trav7d-3. | ||||||
Chelerythrine | 34316-15-9 | sc-507380 | 100 mg | $540.00 | ||
Chelerythrine is a PKC inhibitor that can paradoxically activate certain PKC isoforms under specific conditions, potentially leading to Trav7d-3 activation. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I selectively inhibits PKC, which can lead to compensatory activation of alternative pathways that activate Trav7d-3. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum kinase inhibitor that can inadvertently activate certain kinases through feedback loops, potentially leading to Trav7d-3 activation. | ||||||